Fangzhou Inc. ("Fangzhou" or the "Company") (HKEX: 06086), a leader in AI-driven Internet healthcare solutions, and Shanghai ...
MedPage Today on MSN
More Trial Details Reported for Novel Psoriasis Pill
Subgroup analyses from one of the agent's pivotal trials showed that 29.5% of adolescents receiving icotrokinra achieved PASI ...
Fangzhou Inc. ("Fangzhou" or the "Company") (HKEX: 06086), a leader in AI-driven Internet healthcare solutions, and Shanghai ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback